Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Spironolactone for Pulmonary Arterial Hypertension [Phase 2]
A Phase 2 clinical trial evaluating spironolactone for pulmonary arterial hypertension is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension [Phase 1]
A Phase 1 clinical trial is evaluating the safety and tolerability of artesunate in patients with Pulmonary Arterial Hypertension. The study…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension [Phase 1, Phase 2]
Pfizer is conducting a Phase 1/Phase 2 study to evaluate PF-07868489 in healthy adults and in patients with pulmonary arterial hypertension.…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) [Phase 2]
A Phase 2 study evaluating REGN13335 in adults with pulmonary arterial hypertension is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study of Intravenous ZMA001 in Healthy Subjects [Phase 1]
Phase 1 study evaluating intravenous ZMA001 in healthy subjects to characterize safety, tolerability, and pharmacokinetics, with the trial l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) [Phase 3]
This update describes a Phase 3 study of Sotatercept (MK-7962) for pulmonary arterial hypertension. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Pulmonary Hypertension Peripheral Limitations [NA]
A Mayo Clinic clinical trial studying pulmonary hypertension, including pulmonary arterial hypertension patients and healthy volunteers, is …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) [Phase 2]
A Phase 2 clinical trial update for ROC-101 in patients with pulmonary arterial hypertension and pulmonary hypertension due to interstitial …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension [NA]
This clinical trial update indicates that the study on the evolution of hypoxic burden and autonomic balance in patients with precapillary p…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
This entry describes a natural history study investigating biomarkers in pulmonary arterial hypertension, with recruitment currently ongoing…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension [Phase 3]
Phase 3 clinical trial evaluating selexipag as add-on therapy to standard of care for children with pulmonary arterial hypertension. The spo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension [Phase 3]
This clinical trial update describes a Phase 3 outcome study evaluating a 75 mg dose of macitentan in patients with pulmonary arterial hyper…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Sotatercept in Pulmonary Arterial Hypertension [Phase 4]
Phase 4 trial update for Sotatercept in pulmonary arterial hypertension shows the study is currently recruiting. Sponsor is the University o…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension [Phase 2, Phase 3]
A clinical trial update on Oxacom evaluating efficacy and safety in patients with pulmonary arterial hypertension in Phase 2/3. The trial is…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University-sponsored trial evaluating pharmacokinetics, pharmacodynamics, and safety of understudied drugs given to children as part of…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT is a patient registry tracking real-world use of Orenitram for pulmonary arterial hypertension.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD [Phase 3]
This clinical trial update notes a Phase 3 study evaluating the safety and tolerability of L606 in patients with pulmonary arterial hyperten…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) [NA]
Update on the RELIEVE-PAH trial evaluating a V-Wave device to reduce right ventricular failure in pulmonary arterial hypertension. The study…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome [Phase 2]
A Phase 2 clinical trial evaluating sotatercept in patients with congenital heart disease and Eisenmenger syndrome is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Mobile Health Intervention to Improve Exercise in Pediatric PH [NA]
A pediatric pulmonary arterial hypertension trial evaluating a mobile health intervention to improve exercise, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.
This clinical trial update outlines an investigational longitudinal study to evaluate reverse remodeling of the pulmonary vasculature with S…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) [Phase 3]
A Phase 3 study evaluating the efficacy and safety of once-daily Treprostinil Palmitil Inhalation Powder (TPIP) in participants with pulmona…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension [Phase 1]
A Phase 1 clinical trial is evaluating the efficacy and safety of empagliflozin for treatment of pulmonary arterial hypertension; the study …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension [NA]
A clinical trial update on validating a Patient Knowledge Questionnaire for pulmonary hypertension is currently recruiting, sponsored by Uni…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) [Phase 1, Phase 2]
Ongoing Phase 1/2 study evaluating LTP001 in healthy volunteers and patients with pulmonary arterial hypertension, currently recruiting.